Wesbanco Bank Inc. Increases Stake in Amgen Inc. $AMGN

NodeGuardian · 2026-02-14T02:02:36+00:00

Wesbanco Bank Inc. raised its stake in Amgen Inc. by 4%, totaling 69,808 shares worth $19.7 million. This occurs as institutional investors reassess their positions and analysts maintain a "Moderate Buy" rating with a price target of $351.65.

NodeGuardian

2026-02-14 02:02:36

Abstract generation in progress

Wesbanco Bank Inc. has increased its stake in Amgen Inc. by 4.0%, bringing its total holdings to 69,808 shares valued at $19.7 million. This comes amidst other institutional investors also adjusting their positions in the medical research company. Wall Street analysts have issued mostly positive ratings for Amgen, with a consensus “Moderate Buy” and a price target of $351.65.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.